AbbVie gets priority review for Imbruvica-Gazyva combo in CLL, SLL
Abbott Labs posts solid Q3 earnings
Express Scripts to cover Amgen, Lilly migraine drugs but not Teva’s
Roche dumps several R&D programs from pipeline
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*
Today's most popular searches:
For banking news and anonymous forums, be sure to check out cafebanking.com
